Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 3/20 | 0.35 |
| ▸ | PRKCA | P17252 | 7/20 | 0.33 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3420193 | 0.86 | — | — | |
| SCHEMBL3419584 | 0.85 | SIRT2 (0.36) | SIRT2 | |
| SCHEMBL3417778 | 0.85 | ALDH1A1 (0.40) | SIRT2 | |
| SCHEMBL3422027 | 0.83 | SMN1; SMN2 (0.42) | SIRT2 | |
| SCHEMBL7085715 | 0.82 | — | — | |
| SCHEMBL3419950 | 0.82 | LMNA (0.44) | SIRT2 | |
| SCHEMBL3417842 | 0.82 | LMNA (0.44) | SIRT2 | |
| SCHEMBL3416194 | 0.82 | LMNA (0.44) | SIRT2 | |
| SCHEMBL9452415 | 0.79 | SIRT2 (0.56) | SIRT2 | |
| SCHEMBL10907793 | 0.79 | SIRT2 (0.56) | SIRT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109843935-B | Dispersion liquid | 住友化学株式会社 | 2021-07-27 | — | — | CN | disclosed |
| US-20100302330-A1 | IMAGE FORMATION METHOD AND ACTIVE ENERGY BEAM-CURABLE INK | RISO KAGAKU CORPORATION (JP) | 2010-12-02 | — | — | US | disclosed |
| US-20100130712-A1 | ADAMANTANE DERIVATIVE, RESIN COMPOSITION USING THE SAME, AND RESIN CURED PRODUCT | IDEMITSU KOSAN CO., LTD. (JP) | 2010-05-27 | — | — | US | disclosed |
| US-20040214945-A1 | Catioinically polymerizable composition and ink | RISO KAGAKU CORPORATION (JP) | 2004-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100130712-A1 | ADAMANTANE DERIVATIVE, RESIN COMPOSITION USING THE SAME, AND RESIN CURED PRODUCT | ARCN1, APP, ADAM17 | SIRT2 1401/4885GAA 625/4885PRKCA 2890/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.